UAE Enhances Organ Donor Protection with New Financial and Medical Benefits

The United Arab Emirates has introduced a significant ministerial decision, No. 91 of 2026, issued by the Ministry of Health and Prevention, to provide comprehensive medical and insurance coverage for organ donors and their families. This initiative aims to shield individuals who donate organs to save lives from financial repercussions and undue burdens. The decision ensures that donors receive support for time off work during recovery, along with assistance for travel, accommodation, and home care, all under the principle of “financial neutrality.” This principle guarantees that donors and their families do not incur any financial losses or expenses due to the donation process. Furthermore, healthcare coverage will be maintained for any medical conditions that may arise from the donation.

Crucially, the legislation explicitly states that these benefits do not constitute payment for donated organs or tissues, strictly prohibiting any assistance that could be misconstrued as remuneration or raise concerns about organ trafficking. This new decree builds upon Federal Decree-Law No. 25 of 2023 concerning organ and tissue donation and transplantation, aiming to remove practical obstacles that might deter voluntary and informed donation decisions.

Dr. Bashir Sankari, transplant director of the Urology Department at the Integrated Surgical Institute, Cleveland Clinic Abu Dhabi, hailed the legislation as an “important development” and a “significant milestone” for organ donation in the UAE. He noted that Cleveland Clinic Abu Dhabi has performed 1,214 organ transplants since 2017, with 200 in 2026, underscoring the need for a robust donation system. Dr. Sankari believes the new measures will alleviate financial and logistical burdens, providing reassurance to potential donors and their families, and recognizing their generosity in giving others a second chance at life.

The decision also encourages charitable and humanitarian organizations, health authorities, insurance schemes, community organizations, and corporate social responsibility entities to contribute to donor support programs. The National Centre for Regulation of Human Organ and Tissue Donation and Transplantation will lead the implementation of these programs in coordination with relevant authorities, assessing support based on individual circumstances and maintaining medical and ethical requirements.

Support extends to the families of deceased donors, who may receive psychological and social support programs. Donors and their relatives will also be eligible for certificates of appreciation, honorary medals, and official letters of thanks. Dr. Sankari expressed optimism that this decree will build on the UAE's transplantation progress, encouraging greater participation in organ donation and offering renewed hope to patients awaiting transplants.